Aptinyx

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptinyx and other ETFs, options, and stocks.

About APTX

Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. 

CEO
Andrew Kidd
CEOAndrew Kidd
Employees
40
Employees40
Headquarters
Evanston, Illinois
HeadquartersEvanston, Illinois
Founded
2015
Founded2015
Employees
40
Employees40

APTX Key Statistics

Market cap
19.39M
Market cap19.39M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
174.29K
Average volume174.29K
High today
$0.2902
High today$0.2902
Low today
$0.2704
Low today$0.2704
Open price
$0.2752
Open price$0.2752
Volume
43.73K
Volume43.73K
52 Week high
$3.76
52 Week high$3.76
52 Week low
$0.20
52 Week low$0.20

Analyst ratings

57%

of 7 ratings
Buy
57.1%
Hold
42.9%
Sell
0%

APTX Earnings

-$0.35
-$0.23
-$0.12
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 22, After Hours
ActualExpected Mar 22, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.